(Reuters) – Italy has held talks with several manufacturers about starting production of mRNA-based COVID-19 vaccines in the country, the Financial Times reported https://www.ft.com/content/d4a9e726-4112-461b-a383-5ad9df062712.
Rome has discussed the domestic production of mRNA-based vaccines with Moderna Inc, Switzerland’s Novartis AG and Italy’s ReiThera, the report added, citing people familiar with the matter.
(Reporting by Aakriti Bhalla in Bengaluru; Editing by Christopher Cushing)
